Page 145 - 南京医科大学学报自然科学版
P. 145
第43卷第9期 赵越桃,胡雅慧,郭宏丽,等. 治疗药物监测在西罗莫司用于儿童期脉管异常中的研究进展[J].
2023年9月 南京医科大学学报(自然科学版),2023,43(9):1319-1323 ·1323 ·
limus,and cyclosporine ⁃ a by mass spectrometry[J]. [31] MORRIS R G,SALM P,TAYLOR P J,et al. Comparison
Transplant Proc,2020,52(5):1402-1408 of the reintroduced MEIA assay with HPLC⁃MS/MS for the
[24] NGUYEN T T,DUONG V A,VO D K,et al. Development determination of whole⁃blood sirolimus from transplant re⁃
and validation of a bioanalytical LC⁃MS/MS method for si⁃ cipients[J]. Ther Drug Monit,2006,28(2):164-168
multaneous determination of sirolimus in porcine whole [32] JOHNSON⁃DAVIS K L,DE S,JIMENEZ E,et al. Evalua⁃
blood and lung tissue and pharmacokinetic application tion of the Abbott ARCHITECT i2000 sirolimus assay
with coronary stents[J]. Molecules,2021,26(2):425 and comparison with the Abbott IMx sirolimus assay and
[25] TAIBON J,VAN ROOIJ M,SCHMID R,et al. An isotope an established liquid chromatography⁃tandem mass spec⁃
dilution LC⁃MS/MS based candidate reference method for trometry method[J]. Ther Drug Monit,2011,33(4):453-
the quantification of cyclosporine A,tacrolimus,sirolimus 459
and everolimus in human whole blood[J]. Clin Biochem, [33] DURAN⁃ROMERO A J,HERNANDEZ⁃RODRIGUEZ J
2020,82:73-84 C,ORTIZ⁃ALVAREZ J,et al. Efficacy and safety of oral
[26] BRESSAN I G,GIMENEZ M I,LLESUY S F. Validation sirolimus for high⁃flow vascular malformations in real clini⁃
of a simple liquid chromatography coupled to tandem cal practice[J]. Clin Exp Dermatol,2022,47(1):57-62
mass spectrometry method for the simultaneous determi⁃ [34] FREIXO C,FERREIRA V,MARTINS J,et al. Efficacy
nation of tacrolimus,sirolimus,everolimus and cyclospo⁃ and safety of sirolimus in the treatment of vascular anoma⁃
rin A in dried matrix on paper discs[J]. J Mass Spectrom lies:a systematic review[J]. J Vasc Surg,2020,71(1):
Adv Clin Lab,2021,19:7-19 318-327
[27] LIU B,GENG N,ZHAO H,et al. Development of UHPLC⁃ [35] WIEGAND S,WICHMANN G,DIETZ A. Treatment of
MS/MS method for simultaneous determination of tacroli⁃ lymphatic malformations with the mTOR inhibitor sirolim⁃
mus and sirolimus in human whole blood and compari⁃ us:a systematic review[J]. Lymphat Res Biol,2018,16
sons with two immunoassays[J]. Biomed Chromatogr, (4):330-339
2023,37(2):e5538 [36] ERICKSON J,MCAULIFFE W,BLENNERHASSETT L,
[28] 杨旭萍,蒋振伟,蒋 艳,等. LC⁃MS/MS 法测定人全血 et al. Fibroadipose vascular anomaly treated with sirolimus:
中他克莫司和西罗莫司浓度及临床应用[J]. 中南药 successful outcome in two patients[J]. Pediatr Dermatol,
学,2022,20(11):2514-2519 2017,34(6):317-320
[29] ZHAO Y T,DAI H R,LI Y,et al. Comparison of LC⁃MS/ [37] ADAMS D M,RICCI K W. Vascular anomalies:diagnosis
MS and EMIT methods for the precise determination of of complicated anomalies and new medical treatment op⁃
blood sirolimus in children with vascular anomalies[J]. tions[J]. Hematol Oncol Clin North Am,2019,33(3):
Front Pharmacol,2022,13:925018 455-470
[30] SALM P,TAYLOR P J,PILLANS P I. The quantification [38] 胡雅慧,郭宏丽,夏 颖,等. 西罗莫司与儿童脉管异常
of sirolimus by high⁃performance liquid chromatography⁃ 的药物治疗:所知与须知[J]. 南京医科大学学报(自然
tandem mass spectrometry and microparticle enzyme im⁃ 科学版),2021,41(12):1829-1836
munoassay in renal transplant recipients[J]. Clin Ther, [收稿日期] 2023-03-29
2000,22(Suppl B):71-85 (本文编辑:陈汐敏)